Several drugs can keep you awake, ranging from the caffeine in your morning coffee to prescription medications designed specifically to promote wakefulness. The most commonly prescribed options fall into two categories: traditional stimulants like amphetamines and methylphenidate, and a newer class of wakefulness-promoting agents (called eugeroics) like modafinil and armodafinil. Which one a person takes depends on the underlying reason for their sleepiness and how their body responds.
Caffeine: The Most Widely Used Option
Caffeine is the world’s most popular wakefulness drug. It works partly by blocking a chemical in the brain called adenosine, which builds up throughout the day and makes you feel sleepy. It also appears to achieve some of its alertness-boosting effect by triggering a small release of dopamine, the same brain chemical targeted by stronger prescription stimulants. For most people, caffeine’s effects peak within 30 to 60 minutes and linger for several hours, though sensitivity varies widely from person to person.
Modafinil and Armodafinil
Modafinil (sold as Provigil) and its longer-lasting cousin armodafinil (Nuvigil) are prescription medications approved for three conditions: narcolepsy, obstructive sleep apnea, and shift work disorder. They sit in a class of their own, distinct from traditional stimulants. While their exact mechanism isn’t fully understood, brain imaging research published in JAMA found that modafinil blocks dopamine transporters and raises dopamine levels in key brain regions, including the reward center. The drug also appears to influence several other signaling systems involving histamine, norepinephrine, and glutamate, which may explain why its effects feel different from those of amphetamines.
In practical terms, modafinil tends to produce a smoother, less jittery sense of alertness compared to traditional stimulants. It doesn’t typically cause the “wired” feeling or the crash that comes with amphetamines. Modafinil reaches its peak effect several hours after you take it, and the average half-life is about 14 hours, meaning half the drug is still active in your system after that time. Armodafinil has a slightly longer half-life of roughly 16.5 hours, which can help people who need sustained wakefulness further into the day.
The most common side effects are headaches, nausea, dizziness, dry mouth, and difficulty sleeping (particularly if taken too late in the day). Rare but serious skin reactions have been reported: between 1998 and 2007, the FDA documented six cases of severe hypersensitivity reactions including Stevens-Johnson syndrome. Modafinil also interacts with a number of other medications. Notably, it can reduce the effectiveness of oral contraceptives, certain blood pressure medications, anti-seizure drugs, and some HIV treatments. It can increase the concentration of antidepressants and blood thinners like warfarin.
Traditional Stimulants: Amphetamines and Methylphenidate
Amphetamines (like Adderall and Dexedrine) and methylphenidate (Ritalin, Concerta) are older, more potent wakefulness drugs. They work by directly increasing dopamine release in the brain and are highly effective at boosting vigilance and attention. These medications are commonly associated with ADHD treatment, but they’re also prescribed for narcolepsy and severe daytime sleepiness that doesn’t respond to other options.
Methylphenidate is often started at 10 mg twice per day, with the second dose given no later than about 3 PM to avoid disrupting nighttime sleep. The dose can be gradually increased over weeks based on how well it works and how well it’s tolerated. Many people with narcolepsy find that extended-release versions wear off after four to six hours, so a second dose in the early afternoon is common. Amphetamines follow a similar pattern but tend to be more potent and carry a higher risk of side effects like elevated heart rate, appetite suppression, and anxiety.
The main tradeoff with traditional stimulants is their higher potential for dependence and abuse compared to eugeroics. They produce a more pronounced dopamine surge, which is why they feel more “stimulating” but also why tolerance can develop faster.
Solriamfetol: A Newer Alternative
Solriamfetol (brand name Sunosi) was approved by the FDA in 2019 for excessive daytime sleepiness caused by narcolepsy or obstructive sleep apnea. It works by blocking the reuptake of both dopamine and norepinephrine in the brain, raising levels of both chemicals in areas involved in alertness and focus. Unlike traditional stimulants, it doesn’t actively force the release of these chemicals, which gives it a milder profile.
Solriamfetol reaches its peak concentration about two hours after you take it and has a half-life of roughly seven hours, making it shorter-acting than modafinil. Common side effects include decreased appetite, headache, nausea, and anxiety. It’s not suitable for people with poorly controlled high blood pressure or those taking a class of antidepressants called MAOIs. Because the drug is cleared almost entirely through the kidneys with very little breakdown by the liver, people with significant kidney problems need a lower dose or may not be able to take it at all.
How These Drugs Compare in Practice
- Duration: Armodafinil lasts the longest (half-life around 16.5 hours), followed by modafinil (about 14 hours), then solriamfetol (about 7 hours). Methylphenidate’s extended-release form often wears off in 4 to 6 hours for people with narcolepsy.
- Strength of effect: Amphetamines produce the most powerful wakefulness but carry the highest risk of side effects and dependence. Modafinil and armodafinil offer a more moderate, sustained alertness. Solriamfetol falls somewhere in between.
- Dependence risk: Traditional stimulants have the highest abuse potential. Modafinil was initially thought to have very low risk, but case reports have documented patterns of craving, tolerance, and withdrawal. Withdrawal symptoms tend to be the opposite of the drug’s effects: lethargy, anxiety, tremors, and disrupted sleep.
- Approved uses: Modafinil and armodafinil cover narcolepsy, obstructive sleep apnea, and shift work disorder. Solriamfetol covers narcolepsy and obstructive sleep apnea. Amphetamines and methylphenidate are used for narcolepsy and ADHD.
Tolerance and Dependence Concerns
All wakefulness drugs that act on dopamine carry some risk of tolerance, meaning you may need higher doses over time to get the same effect. This is most pronounced with amphetamines and least pronounced with modafinil, though it’s not zero. Modafinil’s dopamine-blocking action in the brain’s reward pathways explains why dependence can develop even with a drug that was once considered very low-risk. Withdrawal from modafinil, when it occurs, typically involves lethargy, hand tremors, anxiety, and erratic sleep patterns.
For people using these medications as prescribed for a diagnosed sleep disorder, the risk of problematic dependence is considerably lower than for those using them recreationally or for cognitive enhancement. The key distinction is whether the drug is compensating for an underlying neurological deficit or artificially pushing a healthy brain past its normal limits. In the latter case, the brain tends to adapt more aggressively, leading to a faster cycle of tolerance and dose escalation.